Free shipping on all orders over $ 500

Pranlukast

Cat. No. M3285

All AbMole products are for research use only, cannot be used for human consumption.

Pranlukast Structure
Synonym:

ONO-1078

Size Price Availability Quantity
100mg USD 110 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Pranlukast is a selective cysteinyl leukotriene receptor antagonist. Pranlukast has an anti-inflammatory effect on bronchial eosinophilic infiltration. Pranlukast is now widely used in the treatment of asthma. Many clinical studies have indicated that pranlukast is well tolerated and is effective in reducing bronchial hyperresponsiveness and allergen-induced bronchoconstriction. The anti-asthmatic effect of pranlukast may be rendered not only by antileukotriene activity, but also by pharmacological activity including antieosinophilic effects.

Chemical Information
Molecular Weight 481.5
Formula C27H23N5O4
CAS Number 103177-37-3
Form Solid
Solubility (25°C) DMSO 10 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Xiao-Yan Ye, et al. Effect of pranlukast on neonatal rats with periventricular leukomalacia

[2] Ins Velzquez-Quesada, et al. Pranlukast Antagonizes CD49f and Reduces Stemness in Triple-Negative Breast Cancer Cells

[3] Hoang Kim Tu Trinh, et al. Asthma pharmacotherapy: an update on leukotriene treatments

[4] Hiroto Matsuse, et al. Leukotriene receptor antagonists pranlukast and montelukast for treating asthma

[5] Susan J Keam, et al. Pranlukast: a review of its use in the management of asthma

Related Leukotriene Receptor Products
Zafirlukast

Zafirlukast is a leukotriene receptor antagonist (LTRA) with IC50 of 0.6μM (IC50=7.0 µM for CYP2C9).

Cyclopentyl Chloroformate

Mandelic acid derivatives and their use as thrombin inhibitors.

LY255283

LY255283 is a competitive leukotriene B4 receptor antagonist, with an IC50 of about 100 nM.

CP-424174

CP-424174 is a cytokine release inhibitory compound (CRID) and also a reversible IL-1β inhibitor with an IC50 of 210 nM, which inhibits post-translational processing and secretion of IL-1β in human monocytes in the presence of LPS and ATP.

CP-105,696

CP-105,696 is an orally active, potent and selective leukotriene B4 receptor (LTB4R) antagonist (IC50 against [3H]LTB4 = 5.

  Catalog
Abmole Inhibitor Catalog




Keywords: Pranlukast, ONO-1078 supplier, Leukotriene Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.